Second Line Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$408K Buy
4,785
+15
+0.3% +$1.34K 0.08% 101
2025
Q4
$377K Hold
4,770
0.08% 90
2025
Q3
$381K Hold
4,770
0.08% 90
2025
Q2
$434K Hold
4,770
0.1% 81
2025
Q1
$447K Buy
4,770
+1,418
+42% +$127K 0.12% 74
2024
Q4
$305K Hold
3,352
0.08% 90
2024
Q3
$348K Hold
3,352
0.09% 84
2024
Q2
$325K Buy
3,352
+900
+37% +$83K 0.1% 80
2024
Q1
$221K Buy
+2,452
New +$208K 0.07% 102

Other funds holding CL

Second Line Capital's CL Position: Q1 2026 in Review

Second Line Capital increased its Colgate-Palmolive (CL) stake by 0.31% in Q1 2026, buying an estimated $1.34K and bringing the position to 4,785 shares worth $408K. The position accounts for 0.08% of the portfolio, ranked #101.

Second Line Capital first reported a position in CL in Q1 2024 and has held it in 9 quarters since. The position peaked at $447K in Q1 2025. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Second Line Capital held 4,785 shares of Colgate-Palmolive worth $408K as of Q1 2026.
  • Second Line Capital bought 15 Colgate-Palmolive shares in Q1 2026, an estimated $1.34K.
  • Colgate-Palmolive made up 0.08% of Second Line Capital's portfolio in Q1 2026, its #101 holding.
  • Second Line Capital first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 9 quarters since.
  • Second Line Capital's Colgate-Palmolive position peaked at $447K in Q1 2025.
  • 1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Second Line Capital's 13F filing for Q1 2026, filed 15 May 2026.